Real-life Assessment of Chronic Rhinosinusitis Patients Using Mobile Technology: The MySinusitisCoach Project by EUFOREA

Background: Chronic rhinosinusitis (CRS) is a chronic inflammatory disease associated with a substantial personal and socioeconomic burden. Monitoring of patient-reported outcomes by mobile technology offers the possibility to better understand real-life burden of CRS.

Methods: This study reports on the cross-sectional evaluation of data of 626 users of mySinusitisCoach (mSC), a mobile application for CRS patients. Patient characteristics of mSC users were analysed as well as the level of disease control based on VAS global rhinosinusitis symptom score and adapted EPOS criteria.

Results: The mSC cohort represents a heterogeneous group of CRS patients with a diverse pattern of major symptoms. Approximately half of patients reported nasal polyps. 47.3% of all CRS patients were uncontrolled based on evaluation of VAS global rhinosinusitis symptom score compared to 40.9% based on adapted EPOS criteria. The impact of CRS on sleep quality and daily life activities was significantly higher in uncontrolled versus well-controlled patients. Half of patients had a history of FESS (functional endoscopic sinus surgery) and reported lower symptom severity compared to patients without a history of FESS, except for patients with a history of more than 3 procedures. Patients with a history of FESS reported higher VAS levels for impaired smell.

Conclusion: Real-life data confirm the high disease burden in uncontrolled CRS patients, clearly impacting quality of life. Sinus surgery improves patient-reported outcomes, but not in patients with a history of more than 3 procedures. Mobile technology opens a new era of real-life monitoring, supporting the evolution of care towards precision medicine.

Citing Articles

The Impact and Burden of Chronic Rhinosinusitis with Nasal Polyps on Patients and Their Family Caregivers: A Nationally Representative Survey.

Malvezzi L, Seccia V, Moffa A, Canevari F, Baiardini I, Barbaglia S Healthcare (Basel). 2025; 13(4).

PMID: 39997305 PMC: 11855350. DOI: 10.3390/healthcare13040430.

Intranasal insulin for the treatment of olfactory dysfunction: a protocol for a systematic review and meta-analysis.

He X, Chen X, Mou D, Chen F, Xie Y, Cui W BMJ Open. 2024; 14(11):e090554.

PMID: 39532357 PMC: 11575286. DOI: 10.1136/bmjopen-2024-090554.

Real-Life Study of Patient Preference for Dupilumab or Revision Surgery for Recurrent Chronic Rhinosinusitis with Nasal Polyps.

Gangl K, Liu D, Bartosik T, Campion N, Vyskocil E, Mueller C J Pers Med. 2024; 14(4).

PMID: 38672965 PMC: 11051141. DOI: 10.3390/jpm14040338.

[LASSO regression based risk prediction model for postoperative control in chronic sinusitis with nasal polyps].

Huang H, Yang P, Zhang D Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024; 38(3):200-206.

PMID: 38433687 PMC: 11233208. DOI: 10.13201/j.issn.2096-7993.2024.03.004.

Development of a mobile app for the evaluation of patients with chronic rhinosinusitis.

Ferraiolo P, Junior S, Cruz F, Ramos P, Elabras Filho J, Marques M Braz J Otorhinolaryngol. 2024; 90(2):101375.

PMID: 38237485 PMC: 10828589. DOI: 10.1016/j.bjorl.2023.101375.

References

Doulaptsi M, Prokopakis E, Seys S, Pugin B, Steelant B, Hellings P . Visual analogue scale for sino-nasal symptoms severity correlates with sino-nasal outcome test 22: paving the way for a simple outcome tool of CRS burden. Clin Transl Allergy. 2018; 8:32. PMC: 6120084. DOI: 10.1186/s13601-018-0219-6. View

Rudmik L, Soler Z, Hopkins C, Schlosser R, Peters A, White A . Defining appropriateness criteria for endoscopic sinus surgery during management of uncomplicated adult chronic rhinosinusitis: a RAND/UCLA appropriateness study. Rhinology. 2016; 54(2):117-28. DOI: 10.4193/Rhino16.023. View

Hellings P, Borrelli D, Pietikainen S, Agache I, Akdis C, Bachert C . European Summit on the Prevention and Self-Management of Chronic Respiratory Diseases: report of the European Union Parliament Summit (29 March 2017). Clin Transl Allergy. 2018; 7:49. PMC: 5745781. DOI: 10.1186/s13601-017-0186-3. View

Fokkens W, Lund V, Bachert C, Mullol J, Bjermer L, Bousquet J . EUFOREA consensus on biologics for CRSwNP with or without asthma. Allergy. 2019; 74(12):2312-2319. PMC: 6972984. DOI: 10.1111/all.13875. View

Hellings P, Fokkens W, Bachert C, Akdis C, Bieber T, Agache I . Positioning the principles of precision medicine in care pathways for allergic rhinitis and chronic rhinosinusitis - A EUFOREA-ARIA-EPOS-AIRWAYS ICP statement. Allergy. 2017; 72(9):1297-1305. DOI: 10.1111/all.13162. View

Hirsch A, Stewart W, Sundaresan A, YOUNG A, Kennedy T, Greene J . Nasal and sinus symptoms and chronic rhinosinusitis in a population-based sample. Allergy. 2016; 72(2):274-281. PMC: 5497579. DOI: 10.1111/all.13042. View

Gevaert P, Calus L, Van Zele T, Blomme K, De Ruyck N, Bauters W . Omalizumab is effective in allergic and nonallergic patients with nasal polyps and asthma. J Allergy Clin Immunol. 2012; 131(1):110-6.e1. DOI: 10.1016/j.jaci.2012.07.047. View

Lin D, Chandra R, Tan B, Zirkle W, Conley D, Grammer L . Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy. 2011; 25(4):205-8. PMC: 3390198. DOI: 10.2500/ajra.2011.25.3613. View

Khan A, Vandeplas G, Huynh T, Joish V, Mannent L, Tomassen P . The Global Allergy and Asthma European Network (GALEN rhinosinusitis cohort: a large European cross-sectional study of chronic rhinosinusitis patients with and without nasal polyps. Rhinology. 2018; 57(1):32-42. DOI: 10.4193/Rhin17.255. View

10.

Kohli P, Naik A, Farhood Z, Ong A, Nguyen S, Soler Z . Olfactory Outcomes after Endoscopic Sinus Surgery for Chronic Rhinosinusitis: A Meta-analysis. Otolaryngol Head Neck Surg. 2016; 155(6):936-948. DOI: 10.1177/0194599816664879. View

11.

Hummel T, Whitcroft K, Andrews P, Altundag A, Cinghi C, Costanzo R . Position paper on olfactory dysfunction. Rhinol Suppl. 2018; 54(26):1-30. DOI: 10.4193/Rhino16.248. View

12.

Bachert C, Pawankar R, Zhang L, Bunnag C, Fokkens W, Hamilos D . ICON: chronic rhinosinusitis. World Allergy Organ J. 2014; 7(1):25. PMC: 4213581. DOI: 10.1186/1939-4551-7-25. View

13.

Hastan D, Fokkens W, Bachert C, Newson R, Bislimovska J, Bockelbrink A . Chronic rhinosinusitis in Europe--an underestimated disease. A GA²LEN study. Allergy. 2011; 66(9):1216-23. DOI: 10.1111/j.1398-9995.2011.02646.x. View

14.

Smith K, Orlandi R, Oakley G, Meeks H, Curtin K, Alt J . Long-term revision rates for endoscopic sinus surgery. Int Forum Allergy Rhinol. 2018; 9(4):402-408. PMC: 6438735. DOI: 10.1002/alr.22264. View

15.

Seys S, De Bont S, Fokkens W, Bachert C, Alobid I, Bernal-Sprekelsen M . Real-life assessment of chronic rhinosinusitis patients using mobile technology: The mySinusitisCoach project by EUFOREA. Allergy. 2020; 75(11):2867-2878. PMC: 7687134. DOI: 10.1111/all.14408. View

16.

Fokkens W, Lund V, Mullol J, Bachert C, Alobid I, Baroody F . European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl. 2012; 23. View

17.

Gevaert P, Van Bruaene N, Cattaert T, Van Steen K, Van Zele T, Acke F . Mepolizumab, a humanized anti-IL-5 mAb, as a treatment option for severe nasal polyposis. J Allergy Clin Immunol. 2011; 128(5):989-95.e1-8. DOI: 10.1016/j.jaci.2011.07.056. View

18.

Tomassen P, Vandeplas G, Van Zele T, Cardell L, Arebro J, Olze H . Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016; 137(5):1449-1456.e4. DOI: 10.1016/j.jaci.2015.12.1324. View

19.

DeConde A, Mace J, Levy J, Rudmik L, Alt J, Smith T . Prevalence of polyp recurrence after endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis. Laryngoscope. 2016; 127(3):550-555. PMC: 5321782. DOI: 10.1002/lary.26391. View

20.

Ostovar A, Fokkens W, Pordel S, Movahed A, Ghasemi K, Marzban M . The prevalence of asthma in adult population of southwestern Iran and its association with chronic rhinosinusitis: a GALEN study. Clin Transl Allergy. 2019; 9:43. PMC: 6717339. DOI: 10.1186/s13601-019-0283-6. View